Results 181 to 190 of about 132,795 (279)

Incidence of Adverse Drug Reactions Among HIV Patients on Antiretroviral Drugs in Ethiopia: A Systematic Review and Meta-Analysis. [PDF]

AIDS Res Treat
Endalamew SG, Assefa SK, Getachew MS, Arage FG, Asgedom DK, Terefe B, Teshome DF.   +6 more
europepmc   +1 more source

Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates. [PDF]

Pharmaceutics, 2022
Gelé T, Gouget H, Dereuddre-Bosquet N, Furlan V, Le Grand R, Lambotte O, Desjardins D, Barrail-Tran A.   +7 more
europepmc   +1 more source

Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection [PDF]

, 2011
Cohn, J, Maher, D, von Schoen-Angerer, T
core   +2 more sources

Altered Cytokine‐Induced STAT3 and STAT5 Activation of Peripheral T Follicular Helper Cells Contributes to Vaccine‐Non‐Responsiveness in Aging and HIV

Aging Cell, Volume 25, Issue 3, March 2026.
Chronic immune activation and inflammation associated with aging and HIV skew Tfh signaling toward enhanced IL‐2–STAT5 activation, reinforcing IL‐2R expression through a positive feedback loop and suppressing Tfh helper differentiation programs, thereby contributing to impaired vaccine responsiveness.
Sheldon Davis, Jonah Kupritz, Prabhsimran Singh, Savita Pahwa, Suresh Pallikkuth   +4 more
wiley   +1 more source

HIV-1 cell-to-cell infection of macrophages escapes type I interferon and host restriction factors, and is resistant to antiretroviral drugs. [PDF]

PLoS Pathog
Woottum M, Yan S, Durringer A, Mézière L, Bracq L, Han M, Ndiaye-Lobry D, Chaumeil J, Pagès JC, Benichou S.   +9 more
europepmc   +1 more source

Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling. [PDF]

NeuroImmune Pharm Ther, 2023
Sales D, Lin E, Stoffel V, Dickson S, Khan ZK, Beld J, Jain P.   +6 more
europepmc   +1 more source

Substance Use and Sex Index version 2 (SUSI‐2): Validation of a brief questionnaire for the measurement of behaviours associated with transmission of blood borne viruses and sexually transmitted infections

Addiction, Volume 121, Issue 3, Page 670-679, March 2026.
Abstract Aims This study sought to validate a community‐acceptable Substance Use & Sex Index (SUSI) for use in substance use intervention research. SUSI aims to measure behaviours associated with the transmission of blood‐borne viruses (BBV) and sexually transmitted infections (STI) among people who use substances and incorporate contemporary sexual ...
Brendan Clifford, Raimondo Bruno, Liam Acheson, Michael E. Cecilio, Krista J. Siefried, Jack Freestone, Vincent J. Cornelisse, Brendan Crozier, Nicky Bath, Nadine Ezard   +9 more
wiley   +1 more source

Impact of the coronavirus disease 2019 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021. [PDF]

AIDS, 2022
Zhu W, Huang YA, Wiener J, Neblett-Fanfair R, Kourtis AP, Hall HI, Hoover KW.   +6 more
europepmc   +1 more source

HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium. [PDF]

Cells
Kanmogne GD.
europepmc   +1 more source

Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Zoliflodacin is a first‐in‐class oral spiropyrimidinetrione antibiotic being developed for patients with uncomplicated gonorrhea, including those infected with multidrug‐resistant strains. Because zoliflodacin is metabolized by cytochrome P450 3A4 (CYP3A4), concomitant administration with a CYP3A inhibitor has the potential to increase ...
Alison Luckey, Kajal B. Larson, Noha Rayad, Markus Heep, Sophie Delhomme, Gabrielle Kornmann, John P. Mueller, John P. O'Donnell, Seamus O'Brien, Rainard Fuhr, Jean‐Yves Gillon   +10 more
wiley   +1 more source